| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―16 |
Probiotics and Bacteriocins Against SARS-CoV-2: Therapeutic Frontiers and Mechanistic Insights |
Simeng Sun, Xinyue Guo, Simeng Liu, Shuhong Wu, Lei Ma, Hongru Yang |
| 2 |
[GO] |
2024―Nov―30 |
Probiotics and Prebiotics Intervention in Respiratory and Digestive Infections Linked to Covid-19 |
Tahar Amrouche, Sarah Lammi, Djamel Drider |
| 3 |
[GO] |
2022―Nov―08 |
Lactobacillus rhamnosus Restores Antiviral Signaling and Attenuates Cytokines Secretion from Human Bronchial Epithelial Cells Exposed to Cigarette Smoke and Infected with SARS-CoV-2 |
Fabiana Olímpio, Robert Andreata-Santos, Paloma Cristina Rosa, Wellington Santos, Carlos Oliveira, Flavio Aimbire |
| 4 |
[GO] |
2022―Feb―25 |
Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis? |
Leon M. T. Dicks, Shelly M. Deane, Matthew J. Grobbelaar |
| 5 |
[GO] |
2021―Nov―27 |
In Silico Analysis of Bacteriocins from Lactic Acid Bacteria Against SARS-CoV-2 |
Ismail Erol, Seyfullah Enes Kotil, Ozkan Fidan, Ahmet E. Yetiman, Serdar Durdagi, Fatih Ortakci |
| 6 |
[GO] |
2021―Oct―13 |
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial |
Vladimir Ivashkin, Victor Fomin, Sergey Moiseev, Michail Brovko, Roman Maslennikov, Anatoly Ulyanin, et al. (+5) Victoria Sholomova, Maria Vasilyeva, Elizaveta Trush, Oleg Shifrin, Elena Poluektova |
| 7 |
[GO] |
2021―Mar―26 |
The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development |
Shima Moradi-kalbolandi, Keyvan Majidzadeh-A, Mohadeseh Haji Abdolvahab, Neda Jalili, Leila Farahmand |
| 8 |
[GO] |
2021―Feb―03 |
Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection |
Sinjini Patra, Shivam Saxena, Nilanjan Sahu, Biswaranjan Pradhan, Anasuya Roychowdhury |
| 9 |
[GO] |
2020―Nov―23 |
Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19 |
Sounik Manna, Trinath Chowdhury, Ranadhir Chakraborty, Santi M. Mandal |
